
Your Specialty Pharmacy Solutions Leader
Delivering high-touch support for complex oncology, cell and gene, and rare disease therapies.
Patients are at the heart of all we do.
Biologics is a specialty pharmacy leader that creates extraordinary experiences for oncology, cell and gene, and rare disease patients.
With over 30 years of expertise, we are committed to simplifying access to life-changing medications and delivering personalized clinical care that helps patients understand how to take their medication, manage side effects and achieve the best-possible outcomes.
How We Help
Patients
Compassionate, patient-centered care with expert clinical guidance, side-effect
management, adherence support, and financial aid.
Providers
Customized pharmacy solutions that seamlessly integrate with your workflow and elevate patient care.
Biopharma Partners
Innovative, nimble and collaborative solutions that drive access and reach to
patients.
Dan W.
Dan W. shares his cancer journey and the relationship he formed with Biologics nurse and his “guardian angel,” Porscha Scales.Larry H.
Larry H., blood cancer survivor, shares how the Biologics team helped to educate him on his therapy.Karen I.
Karen I. talks about how she was reassured by the Biologics team during her ovarian cancer journey.Teri Swepston
Teri Swepston, VP Provider Sales, shares her WHY.Now Playing

Dan W.
Now Playing

Larry H.
Now Playing

Karen I.
Now Playing

Teri Swepston
News & Stories
Biologics Drug Launches

- immune thrombocytopenia
- oncology
- rare disease
- rilzabrutinib
- Specialty pharmacy
- WAYRILZ
Cary, N.C. , Sept. 10, 2025 – Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease […]

- alpelisib
- HR+/HER2- Advanced Breast Cancer
- oncology
- PIK3CA Mutation
- PIQRAY
- rare disease
- Specialty pharmacy
Cary, N.C., August 7, 2025 – Effective June 15, PIQRAY® (alpelisib) is now exclusively available at Biologics by McKesson, an […]

- alpelisib
- kinase inhibitor
- oncology
- PIK3CA-Related Overgrowth Spectrum (PROS)
- rare disease
- Specialty pharmacy
Cary, N.C. , August 7, 2025 – Effective June 15, VIJOICE® (alpelisib) is now exclusively available at Biologics by McKesson, […]

- ENSACOVE
- Non-Small Cell Lung Cancer
- oncology
- rare disease
- Specialty pharmacy
- Xcovery
Cary, N.C. , July 14, 2025 – Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease […]

- AUGTYRO
- Bristol Myers Squibb
- FDA Approved
- Limited Distribution
- Non-Small Cell Lung Cancer
- NSCLC
- NTRK
- oncology
- rare disease
- Repotrectinib
- ROS1
- Specialty pharmacy
- Targeted Therapy
Cary, N.C., July 1, 2025 – Effective July 1st, Bristol Myers Squibb Co. has reduced its specialty pharmacy network for […]

- Biopharma
- IBTROZI
- Non-Small Cell Lung Cancer
- oncology
- RARE
- rare disease
- ROS1
- Specialty pharmacy
- taletrectinib
Cary, N.C. , June 11, 2025 – Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease […]

- AbbVie
- EMRELIS
- Non-Small Cell Lung Cancer
- rare disease
- Specialty pharmacy
- telisotuzumab vedotin-tllv)
Cary, N.C. , May 20, 2025 – Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease […]

- AVMAPKI
- avutometinib
- defactinib
- FAKZYNJA
- KRAS
- limited specialty pharmacy
- Ovarian Cancer
- RARE
Cary, N.C. , May 9, 2025 – Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease […]

- atrasentan
- Biologics
- immunoglobulin A nephropathy
- McKesson
- oncology
- RARE
- Specialty pharmacy
- VANRAFIA
CARY, N.C., April 3, 2025—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was selected […]

- GOMEKLI
- low-grade glioma
- MEK inhibitor
- mirdametinib
- neurofibromatosis
- oncology
- plexiform neurofibromas
- rare disease
- Specialty pharmacy
CARY, N.C., FEBRUARY 18, 2025—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, has been […]

- oncology
- rare disease
- Romvimza
- Specialty pharmacy
- Tenosynovial Giant Cell Tumor
- vimseltinib
CARY, N.C., February 17, 2025—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, has been […]

- Acute Lymphoid Leukemia
- Acute Myeloid Leukemia
- KMT2Amenin protein
- lysine methyltransferase 2A gene
- REVUFORJ (revumenib)
CARY, N.C., January 24, 2025—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was selected […]

- Azurity Pharmaceuticals
- Danziten
- nilotinib
- pediatric rare
- Ph+ CML
- Philadelphia chromosome
- rare disease
CARY, N.C., December 6, 2024—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, has been […]

2025 Healthcare Advocate Summit
Biologics by McKesson is excited to sponsor the Healthcare Advocate Summit premier event September 2-5, 2025, at Caesars Palace in Las Vegas, NV.

2025 National Association of Specialty Pharmacy (NASP) Annual Meeting & Expo
Biologics by McKesson Specialty Pharmacy is thrilled to be a Bronze level sponsor for the National Association of Specialty Pharmacy 2025 Annual Meeting and Expo September 14 -17, 2025, at the Gaylord Rockies in Denver, CO.